Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes

By Villmow T.   Kemkes-Matthes B.   Matzdorff A.C.  

Thrombosis Research, Vol. 108, Iss. 2, 2002-11 ,pp. : 139-145

Elsevier

Access to resources Recommend Favorite

Determinants of Platelet-Leukocyte Aggregation and Platelet Activation in Stroke

By  

Cerebrovascular Diseases, Vol. 39, Iss. 3-4, 2015-02 ,pp. : 176-180

Karger

Access to resources Recommend Favorite

The GPIIb/IIIa antagonist eptifibatide markedly potentiates platelet-leukocyte interaction and tissue factor expression following platelet activation in whole blood in vitro

By Scholz Thomas   Zhao Lian   Temmler Uta   Bath Philip   Heptinstall Stan   Lösche Wolfgang  

Platelets, Vol. 13, Iss. 7, 2002-11 ,pp. : 401-406

Informa Healthcare

Access to resources Recommend Favorite

Combined Thrombolysis with Abciximab Favourably Influences Platelet-Leukocyte Interactions and Platelet Activation in Acute Myocardial Infarction

By Szabo Sebastian   Etzel Diana   Ehlers Raila   Walter Thomas   Kazmaier Silke   Helber Uwe   Hoffmeister Hans  

Journal of Thrombosis and Thrombolysis, Vol. 20, Iss. 3, 2005-12 ,pp. : 155-161

Springer Publishing Company

Access to resources Recommend Favorite

The complement factor properdin induces formation of platelet-leukocyte aggregates via leukocyte activation

By Ruef Johannes   Kuehnl Peter   Meinertz Thomas   Merten Michael  

Platelets, Vol. 19, Iss. 5, 2008-08 ,pp. : 359-364

Informa Healthcare

Access to resources Recommend Favorite